Legend Biotech (LEGN) Retained Earnings (2019 - 2025)

Legend Biotech has reported Retained Earnings for 7 years, with the latest figure at $1.0 billion in Q4 2025.

• For the quarter ending Q4 2025, Retained Earnings fell 3.7% year-over-year to $1.0 billion; the trailing twelve-month figure through Dec 2025 stood at $1.0 billion (down 3.7% YoY), and the FY2025 full-year result was $1.0 billion, down 3.7% from the prior year.
• Retained Earnings for Q4 2025 stood at $1.0 billion, down from $1.0 billion in the prior quarter.
• The five-year high for Retained Earnings was $1.4 billion in Q2 2023, with the low at $206424.0 in Q1 2021.
• Historically, Retained Earnings has averaged $858.3 million across 5 years, with a median of $1.0 billion in 2025.
• Annual changes were most pronounced in 2021 — Retained Earnings sank 32.56% — and 2022, when it soared 358932.38%.
• Legend Biotech's Retained Earnings stood at $766.0 million in 2021, then fell by 2.87% to $744.0 million in 2022, then jumped by 68.19% to $1.3 billion in 2023, then fell by 16.85% to $1.0 billion in 2024, then slipped by 3.7% to $1.0 billion in 2025.
• The last three Retained Earnings figures came in at $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.